Tata Capital Healthcare Fund on Monday said it has raised up its second India Focused Life Sciences & Healthcare Private Equity Fund of Rs 955 Crores ($126 million).
The PE firm said the latest raise will meet its target assets under management of Rs 950 crores excluding green-shoe.
This was a follow-up to the Tata Capital Healthcare Fund I which had raised Rs 411 crore in 2012.
TCHF-II has received commitments from domestic and international financial and strategic institutions including some of the global pharma, medical equipment firm’s, development financial institutions and large European Institutions
indicating their support for the TCHF investment strategy.
TCHF II also received commitment from the ‘Self Reliant India (SRI)’ Fund of the Government of India under the Ministry of Micro, Small and Medium Enterprises.
“TCHF II will seek to achieve returns by principally taking equity positions in healthcare and life sciences related companies having significant business exposure to India," said Visalakshi Chandramouli, managing partner of TCHF articulating the Fund’s investment strategy said,
“TCHF II will seek to attain returns by principally taking equity positions in healthcare and life sciences related companies having significant business exposure to India," said Visalakshi Chandramouli, managing partner of TCHF articulating the Fund’s investment strategy said,
Chandramouli said the investment strategy of TCHF II will be dedicated on the Indian consumption story in healthcare and life sciences related businesses.
"It is estimated that 60% of TCHF II’s investments will cater to this theme," Chandramouli said.
The second theme of investment is dedicated on leveraging India’s expertise in the healthcare and life sciences sectors to deliver products and services to the world markets.